CN Patent

CN109641868B — 流感病毒复制抑制剂及其使用方法和用途

Assigned to Guangdong HEC Pharmaceutical Co Ltd · Expires 2021-12-03 · 4y expired

What this patent protects

本发明提供一种新的作为流感病毒复制抑制剂的化合物及其制备方法、包含所述化合物的药物组合物以及所述化合物及其药物组合物在制备用于治疗流感的药物中的应用。

USPTO Abstract

本发明提供一种新的作为流感病毒复制抑制剂的化合物及其制备方法、包含所述化合物的药物组合物以及所述化合物及其药物组合物在制备用于治疗流感的药物中的应用。

Drugs covered by this patent

Patent Metadata

Patent number
CN109641868B
Jurisdiction
CN
Classification
—
Expires
2021-12-03
Drug substance claim
No
Drug product claim
No
Assignee
Guangdong HEC Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.